> The authors found that the incidence of pancreatitis — inflammation of the pancreas — was 4.6 times higher in people taking semaglutide than in people taking a weight-loss medication that does not mimic GLP-1. The study also found that semaglutide and liraglutide, another GLP-1 medication, were associated with an increased incidence of gastroparesis, a disorder that slows or stops the movement of food from the stomach to the intestine.
also theyre a bit worried about people becoming obese while having low muscle mass, so an obese skinny person?
Obesity with low muscle mass is sedentary obesity. It's the worst kind but also the most common form - the "dad bod" type of big-gut-big-arms is a smaller chunk of the pie than the "walmart power scooter" type.
It's all horrible, I'm convinced it's microplastics, and we need to get oral GLP-1 drugs ASAP.
also theyre a bit worried about people becoming obese while having low muscle mass, so an obese skinny person?